Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK; Laboratory of Experimental Physiology, Department of Physiology, Biological and Health Sciences Centre, Federal University of Maranhão, São Luís, Brazil; Laboratory of Vascular Biology, Health Institute (InCor), University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Departamento de Métodos Cuantitativos y Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República, Montevideo, Uruguay; Departamento de Bioquímica y Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Free Radic Biol Med. 2021 Aug 20;172:668-674. doi: 10.1016/j.freeradbiomed.2021.07.011. Epub 2021 Jul 9.
We have previously described CxxCpep, a peptide with anti-platelet properties that inhibits peri/epicellular protein disulphide isomerase (pecPDI) by forming a mixed disulfide bond with Cys400 within the pecPDI active site.
Here we sought to determine if pecPDI targeted by CxxCpep is relevant to redox mechanisms downstream of the collagen receptor GPVI in platelets.
Restriction of effects of CxxCpep to the platelet surface was confirmed by LC-MS/MS following cell fractionation. Platelet aggregation was measured in platelet-rich plasma (PRP) incubated with 30 μM CxxCpep or vehicle. CxxCpep inhibited collagen-induced platelet aggregation but exerted no effect in TRAP-6-stimulated platelets. PRP was incubated with DCFDA to measure oxidative burst upon platelet adhesion to collagen. Results showed that CxxCpep decreased oxidative burst in platelets adhered to immobilized collagen while the number of adherent cells was unaffected. Furthermore, flow cytometry studies using a FITC-maleimide showed that the GPVI agonist CRP stimulated an increase in free thiols on the platelet outer membrane, which was inhibited by CxxCpep. Finally, CxxCpep inhibited platelet mitochondrial respiration upon activation with collagen, but not with thrombin.
Our data suggest that pecPDI is a potential modulator of GPVI-mediated redox regulation mechanisms and that CxxCpep can be further exploited as a template for new antiplatelet compounds.
我们之前描述了 CxxCpep,这是一种具有抗血小板特性的肽,通过与 pecPDI 活性位点内的 Cys400 形成混合二硫键来抑制peri/epicellular 蛋白二硫键异构酶(pecPDI)。
本研究旨在确定 CxxCpep 靶向的 pecPDI 是否与血小板中胶原受体 GPVI 下游的氧化还原机制有关。
通过 LC-MS/MS 在细胞分馏后,证实了 CxxCpep 对血小板表面的作用受到限制。在富含血小板的血浆(PRP)中加入 30μM CxxCpep 或载体,测量血小板聚集。CxxCpep 抑制胶原诱导的血小板聚集,但对 TRAP-6 刺激的血小板无作用。用 DCFDA 孵育 PRP,以测量血小板黏附到胶原时的氧化爆发。结果表明,CxxCpep 降低了固定化胶原黏附的血小板中的氧化爆发,而黏附细胞的数量不受影响。此外,使用 FITC-马来酰亚胺的流式细胞术研究表明,GPVI 激动剂 CRP 刺激血小板外膜上自由巯基的增加,而 CxxCpep 抑制了这种增加。最后,CxxCpep 抑制了胶原激活时血小板线粒体呼吸,但不抑制凝血酶。
我们的数据表明,pecPDI 是 GPVI 介导的氧化还原调节机制的潜在调节剂,CxxCpep 可以进一步被开发为新型抗血小板化合物的模板。